Vaccine Companies in BioPortfolio's Corporate Database
Vaccine company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Vaccine companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Vaccine Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Vaccine Companies.
More Information about Vaccine on BioPortfolio
We have published hundreds of Vaccine news stories on BioPortfolio along with dozens of Vaccine Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Vaccine for you to read.
Showing "vaccines vaccine" Companies 1 to 25 of 390
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company headquartered in Hershey, PA with lab facilities in Rockville, MD. ITI is developing next generation vaccines based on its patented LAMP⢠Technology platform. LAMP-Vax⢠vaccine technology has the potential to significantly increase the effectiveness of the...
Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine antigen such as those used in currently marketed influenza, hepatitis B and human papilloma virus (HPV) blockbuster vaccines. Care Capital of Princeton is the lead investor in th...
International Medica Foundation
The International Medica Foundation, which has the rights to RotaShield, is a nonprofit foundation that focuses on ensuring that a safe, effective and affordable rotavirus vaccine is clinically tested and then can be provided to families in need globally. The International Medica Foundation also aims to ensure that the manufacturing process for Rota...
Zoetis (zÅ-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. The company generated annual r...
With the advent of new technologies, in the last four years, DNA sequencing has gone through a technological revolution which has completely changed the market. While in 2007 it still cost over 10 million euros to sequence a complete human genome (the first sequencing cost 3 billion dollars in 2003), in 2012 it cost only $4000 for complete sequencing - and very soon it will be possible to sequen...
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing acce...
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas. Xenetic are also a...
VGTI Florida is the Florida-funded expansion of Oregon Health & Science University's highly successful Vaccine and Gene Therapy Institute. Research at the facility will focus on vaccine development with a special focus on vaccines and therapeutics that protect the aging population, which is the most vulnerable to disease.
Etubics Corporation, based in Seattle, Wash., is a clinical stage bio-pharmaceutical company, which has developed a proprietary platform technology consisting of a next generation Ad5 vector vaccine platform and a manufacturing E.C7 human cell line, collectively the Etubics Platform. Clinical work to date shows that the Etubics Platform overcomes problems...
Synbiosis is a world leading supplier of automatic colony counting and zone measurement systems in microbiology and pharmaceutical applications. The hallmark of all Synbiosis systems is that they will improve the efficiency, reliability and productivity of any laboratory through the use of automated techniques. Synbiosis products are used in the pharmaceutical, healthcare and food manufacturing in...
CytoGenix is a Nevada corporation traded under the symbol: CYGX.PK. CytoGenix is a biotechnology company developing biotechnology derived products for vaccines and therapeutic applications for human, agricultural and veterinary markets. As such, CytoGenix has access to a broad range of biological expertise that can be leveraged to identify, evaluate, devel...
Fraunhofer USA CMB, a division of Fraunhofer USA, Inc., is a not-for-profit research organization whose mission is to develop safe and effective vaccines targeting infectious diseases and autoimmune disorders. CMBâs technology provides a safe, rapid and economical alternative for vaccine production. The Center conducts research in the area of plant bi...
Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mortality. Since its inception in 2003, the Companyâs strategic intent has been to develop and acquire the technologies needed to deliver on that mission within high value mark...
Inviragen, Inc. and PharmaJet, Inc.
Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...
Variation Biotechnologies, Inc.
VBI is an emerging leader in the innovative formulation, delivery and development of vaccines. The Companyâs powerful, proprietary technology platforms enable thermostable IM and thermostable oral vaccine delivery, creating improved dose equivalent and the potential for dose sparing and adjuvanted vaccines, extending vaccine reach and coverage in established...
Genocea Biosciences is a vaccine discovery and development company targeting major infectious diseases with high unmet medical needs, in which T cell response helps confer protection. The companyâs transformational discovery platform mines the natural immune response across diverse human populations in a way that radically reduces the risk, cost and t...
Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease, chikungunya and Japanese encephalitis which affect millions of individuals in Asia. Vaccines in...
Advaxis is a biotechnology company developing proprietary, live but attenuated Listeria monocytogenes (Listeria) vaccines that deliver engineered tumor antigens, which stimulate multiple, simultaneous immunological mechanisms to fight cancer. Our platform technology was developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsy...
Genocea Biosciences is a vaccine discovery and development company targeting major infectious diseases with high unmet medical needs, in which T cell responses help confer protection. The companyâs transformational discovery platform mines the natural immune response across diverse human populations in a way that radically reduces the risk, cost and t...
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We al...
Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We al...
ImmunoCellular Therapeutics, Ltd. and BioWa, Inc.
IMUC is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company recently started a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor associated antigens for newly diagnosed glioblastoma. To learn more about IMU...
Tetragenetics is creating the next generation of vaccines. The companyâs proprietary technologies (TetraExpressâ¢, PRiSMâ¢, and G-Someâ¢), are based upon Tetrahymena thermophila, a sophisticated microorganism that enables the development, manufacture, and delivery of new and improved vaccines to address long-standing and emerging threats to human...
Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, influenza, respiratory syncytial virus and cancer - using a novel proprietary technology. The company is headquartered in Basel, Switzerland and has laboratories in Rome and Naples, Italy.
Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of attenuated and targeted vaccines based on Listeria monocytogenes has been in development for 9 years and has been validated by more than 20 major publications and more than $20 mill...
